Insider · CIK 0001512984

Cox Russell J.

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001512984

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2026-06-04	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2025-06-25	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2024-06-06	GOSSGossamer Bio, Inc. · Non-qualified stock option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2023-06-22	SYRESpyre Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1.95M sh	—	—	1,950,000
2023-06-08	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2022-06-09	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+43K sh	—	—	43,000
2021-06-09	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-06-08	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-17	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2020-06-08	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+28.1K sh	—	—	28,100
2019-06-10	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2019-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,400
2019-02-12	GOSSGossamer Bio, Inc.P Purchase	Director	PPurchase	+7,200 sh	$16.00	+$115K	7,200
2019-01-11	IMUXIMMUNIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.59M sh	—	—	0
2019-01-11	IMUXIMMUNIC, INC. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+1.85M sh	—	—	1,854,376
2018-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2018-01-03	IMUXIMMUNIC, INC. · Non-Qualifed Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.59M sh	—	—	1,588,832
2017-12-11	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP & COO	MExercise/Conversion	+44.2K sh	$8.23	+$364K	96,263
2017-12-11	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP & COO	MExercise/Conversion	+4,867 sh	$46.83	+$228K	101,130
2017-12-11	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP & COO	MExercise/Conversion	+1,691 sh	$59.13	+$100K	102,821
2017-12-11	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	EVP & COO	MExercise/Conversion	−44.2K sh	—	—	0
2017-12-11	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	EVP & COO	MExercise/Conversion	−4,867 sh	—	—	0
2017-12-11	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	EVP & COO	MExercise/Conversion	−1,691 sh	—	—	0
2017-12-01	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2017-08-07	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−978 sh	$155.56	−$152K	51,985
2017-03-06	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−1,793 sh	$132.81	−$238K	52,795
2017-03-02	JAZZJazz Pharmaceuticals plcA Award	EVP & COO	AAward	+10K sh	—	—	54,588
2017-03-02	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	EVP & COO	AAward	+734 sh	—	—	734
2017-03-02	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	EVP & COO	AAward	+24.3K sh	—	—	24,266
2017-02-27	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−2,507 sh	$136.97	−$343K	44,588
2017-01-18	JAZZJazz Pharmaceuticals plcS Sale	EVP & COO	SSale	−1,000 sh	$125.00	−$125K	50,095
2017-01-18	JAZZJazz Pharmaceuticals plcS Sale	EVP & COO	SSale	−3,000 sh	$130.00	−$390K	47,095
2016-08-09	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−4,565 sh	$150.01	−$685K	55,038
2016-08-09	JAZZJazz Pharmaceuticals plcS Sale	EVP & COO	SSale	−4,000 sh	$148.66	−$595K	51,038
2016-08-07	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−978 sh	$149.02	−$146K	59,603
2016-05-17	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-04-12	SYRESpyre Therapeutics, Inc.P Purchase	Director	PPurchase	+7,000 sh	$10.00	+$70K	7,000
2016-04-12	JAZZJazz Pharmaceuticals plcS Sale	EVP & COO	SSale	−4,000 sh	$136.98	−$548K	60,470
2016-03-07	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−1,550 sh	$127.84	−$198K	64,470
2016-02-29	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−939 sh	$121.58	−$114K	66,020
2016-02-26	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−731 sh	$125.00	−$91.4K	66,959
2016-02-25	JAZZJazz Pharmaceuticals plcA Award	EVP & COO	AAward	+9,000 sh	—	—	67,690
2016-02-25	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	EVP & COO	AAward	+811 sh	—	—	811
2016-02-25	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	EVP & COO	AAward	+21.7K sh	—	—	21,689
2015-08-11	JAZZJazz Pharmaceuticals plcS Sale	EVP & COO	SSale	−500 sh	$177.82	−$88.9K	58,602
2015-08-10	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−4,565 sh	$181.48	−$828K	59,102
2015-08-07	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & COO	FTax Payment	−978 sh	$181.79	−$178K	63,667
2015-04-14	JAZZJazz Pharmaceuticals plcS Sale	EVP & COO	SSale	−500 sh	$181.45	−$90.7K	64,553

Recent filings

Accepted (ET)
Sep 254
Cox Russell J.0001628280-26-063601
SEC(opens sec.gov)
Jun 54
Cox Russell J.0001512984-26-000001
SEC(opens sec.gov)
Jun 264
Cox Russell J.0001728117-25-000057
SEC(opens sec.gov)
Jun 64
Cox Russell J.0001728117-24-000065
SEC(opens sec.gov)
Jun 304
Cox Russell J.0001209191-23-040335
SEC(opens sec.gov)
Jun 94
Cox Russell J.0001728117-23-000083
SEC(opens sec.gov)
Jul 154
Cox Russell J.0001728117-22-000073
SEC(opens sec.gov)
Jun 94
Cox Russell J.0001209191-22-035684
SEC(opens sec.gov)
Jun 104
Cox Russell J.0001728117-21-000058
SEC(opens sec.gov)
Jun 94
Cox Russell J.0001209191-21-039224
SEC(opens sec.gov)
Jun 184
Cox Russell J.0001209191-20-037640
SEC(opens sec.gov)
Jun 104
Cox Russell J.0001209191-20-035510
SEC(opens sec.gov)
Jun 114
Cox Russell J.0001209191-19-036216
SEC(opens sec.gov)
Jun 74
Cox Russell J.0001567619-19-013070
SEC(opens sec.gov)
Feb 124
Cox Russell J.0001209191-19-009452
SEC(opens sec.gov)
Jan 144
Cox Russell J.0001280776-19-000018
SEC(opens sec.gov)
Jun 84
Cox Russell J.0001140361-18-027927
SEC(opens sec.gov)
Jan 44
Cox Russell J.0001280776-18-000004
SEC(opens sec.gov)
Dec 134
Cox Russell J.0001628280-17-012316
SEC(opens sec.gov)

Companies

Address

3115 MERRYFIELD ROW, SUITE 120

SAN DIEGO, CA, 92121